Status: Recruiting
IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia
This study is a multicenter, double-blind, randomized placebo controlled, parallel group, superiority trial in order to test the superiority of intramuscular injections of IncobotulinumtoxinA against placebo using a 1:1 allocation ratio.
Participants needed: 48
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Alain KaelinUpdated: Mar 19, 2026Locations: 5
Eligibility criteria
Informed Consent as documented by signature [+6]
Presence of spasticity, or other central sensorimotor lesion of motor system oth... [+11]